Delcath Systems Inc (DCTH)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $714.89M
Last updated: Nov 17, 2026 at 11:03 AM ET
Delcath Systems Inc (DCTH) Financials: Revenue, Profit and Cash Flow
Delcath Systems reported revenue of $85.23M for the fiscal year ended Dec 31, 2025, up 129.1% from the year before. That year, net income was $2.70M with a net margin of 3.2%, operating cash flow was $22.52M and free cash flow was $20.97M. The quarter ended Sep 30, 2026 had revenue of $35.10M and net income of $6.95M.
Revenue and Margins
The operating margin was 0.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.99M, a compound annual rate of 51.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $85.23M | +129.1% | 86.2% | 0.8% | 3.2% |
| Dec 2024 | $37.20M | +1701.7% | 83.4% | -33.4% | -70.9% |
| Dec 2023 | $2.06M | -24.1% | 69.2% | -1849.0% | -2308.9% |
| Dec 2022 | $2.72M | -23.5% | 74.8% | -1245.1% | -1342.7% |
| Dec 2021 | $3.56M | +116.0% | 81.1% | -690.0% | -721.5% |
| Dec 2020 | $1.65M | +4.2% | 61.1% | -1294.2% | -2935.1% |
| Dec 2019 | $1.58M | -53.6% | 54.5% | -1260.0% | -562.0% |
| Dec 2018 | $3.41M | +25.5% | 70.4% | -794.6% | -564.2% |
| Dec 2017 | $2.71M | +36.3% | 74.2% | -669.1% | -1661.8% |
| Dec 2016 | $1.99M | N/A | 72.4% | -825.3% | -902.2% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 737.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85.23M | $37.20M | $2.06M | $2.72M | $3.56M | $1.65M | $1.58M | $3.41M | $2.71M | $1.99M |
| Cost of revenue | $11.80M | $6.19M | $635.00K | $686.00K | $671.00K | $640.00K | $719.00K | $1.01M | $701.00K | $550.00K |
| Gross profit | $73.43M | $31.02M | $1.43M | $2.03M | $2.88M | $1.01M | $861.00K | $2.40M | $2.01M | $1.44M |
| Research and development | $29.25M | $13.87M | $17.50M | $18.58M | $13.78M | $11.20M | $9.49M | $19.65M | $10.49M | $8.45M |
| Operating income | $660.00K | -$12.41M | -$38.18M | -$33.85M | -$24.53M | -$21.30M | -$19.91M | -$27.07M | -$18.16M | -$16.44M |
| Net income | $2.70M | -$26.39M | -$47.68M | -$36.51M | -$25.65M | -$48.31M | -$8.88M | -$19.22M | -$45.12M | -$17.97M |
| EBITDA | N/A | N/A | N/A | -$32.95M | -$23.99M | N/A | $581.00K | -$6.92M | $18.79M | $10.91M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35.10M | $29.13M | $24.99M | $20.73M | $20.56M | $24.16M | $19.78M | $15.10M | $11.20M | $7.77M | $3.14M | $539.00K |
| Gross profit | $31.18M | $26.15M | $21.26M | $17.72M | $17.94M | $20.84M | $16.94M | $12.97M | $9.56M | $6.25M | $2.24M | $368.00K |
| Operating income | $7.12M | $2.40M | -$1.64M | -$2.18M | -$388.00K | $2.59M | $642.00K | $3.04M | -$1.26M | -$3.91M | -$10.28M | -$11.30M |
| Net income | $6.95M | $2.67M | -$1.07M | -$1.90M | $830.00K | $2.70M | $1.07M | -$3.40M | $1.86M | -$13.74M | -$11.11M | -$11.14M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $101.00K by $43.35M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $123.63M | $76.59M | $38.61M | $17.86M | $33.12M | $34.63M | $14.21M | $6.84M | $8.89M | $35.24M |
| Current assets | $119.53M | $73.76M | $37.16M | $16.16M | $31.15M | $32.34M | $12.62M | $5.92M | $7.59M | $34.16M |
| Cash and equivalents | $43.45M | $32.41M | $12.65M | $7.67M | $22.80M | $28.57M | $10.00M | $2.52M | $4.00M | $4.41M |
| Total liabilities | $12.41M | $7.84M | $22.84M | $23.72M | $21.17M | $12.56M | $20.57M | $21.78M | $8.21M | $36.73M |
| Short-term debt | $101.00K | $105.00K | $10.15M | $7.85M | $621.00K | $2.00M | $0 | $2.04M | $0 | $13.34M |
| Long-term debt | N/A | N/A | N/A | $7.84M | $15.01M | $0 | $2.00M | $0 | N/A | N/A |
| Shareholder equity | $111.22M | $68.75M | $15.78M | -$5.86M | $11.95M | $22.08M | -$6.36M | -$14.94M | $678.00K | -$1.49M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $149.09M | $137.02M | $124.84M | $123.63M | $124.30M | $116.88M | $87.32M | $76.59M | $31.68M | $33.91M | $36.10M | $38.61M |
| Total liabilities | $15.55M | $15.87M | $12.13M | $12.41M | $9.45M | $11.89M | $7.09M | $7.84M | $23.11M | $29.72M | $21.48M | $22.84M |
| Cash and equivalents | $55.54M | $47.52M | $41.31M | $43.45M | $41.81M | $34.42M | $12.78M | $32.41M | $8.31M | $14.78M | $11.76M | $12.65M |
| Shareholder equity | $133.54M | $121.14M | $112.71M | $111.22M | $114.85M | $104.99M | $80.23M | $68.75M | $8.57M | $4.19M | $14.62M | $15.78M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 93.1% of operating cash flow. Share repurchases came to 28.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $22.52M | -$18.68M | -$31.25M | -$24.95M | -$22.60M | -$22.87M | -$23.69M | -$14.73M | -$15.40M | -$14.21M |
| Capital expenditures | $1.55M | $559.00K | $58.00K | $209.00K | $143.00K | $782.00K | $24.00K | $76.00K | $524.00K | $258.00K |
| Free cash flow | $20.97M | -$19.24M | -$31.31M | -$25.16M | -$22.75M | -$23.65M | -$23.71M | -$14.81M | -$15.92M | -$14.47M |
| Dividends paid | N/A | N/A | $51.78M | N/A | N/A | $106.00K | $0 | N/A | $527.00K | N/A |
| Share repurchases | $6.00M | $0 | N/A | N/A | N/A | $1.00K | $0 | N/A | N/A | N/A |
| Investing cash flow | -$26.59M | -$981.00K | -$19.71M | -$209.00K | -$143.00K | -$782.00K | -$24.00K | -$76.00K | -$524.00K | -$1.34M |
| Financing cash flow | $15.05M | $39.41M | $51.78M | $10.14M | $20.82M | $42.35M | $30.30M | $13.24M | -$10.52M | $7.41M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $8.18M | $5.71M | $857.00K | $8.25M | $4.77M | $7.29M | $2.20M | -$1.01M | -$3.64M | -$4.45M | -$9.58M | -$8.18M |
| Capital expenditures | $1.26M | $503.00K | $570.00K | $550.00K | $459.00K | $398.00K | $140.00K | $229.00K | $216.00K | $101.00K | $13.00K | $19.00K |
| Free cash flow | $6.92M | $5.21M | $287.00K | $7.70M | $4.31M | $6.89M | $2.06M | -$1.24M | -$3.86M | -$4.55M | -$9.60M | -$8.20M |
Frequently Asked Questions About DCTH
What is Delcath Systems' annual revenue?
Delcath Systems reported revenue of $85.23M for the fiscal year ended Dec 31, 2025.
How fast is Delcath Systems' revenue growing?
Revenue was up 129.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 215.3%.
Is Delcath Systems profitable?
Yes. Delcath Systems reported net income of $2.70M for the fiscal year ended Dec 31, 2025, with a net margin of 3.2%.
How much free cash flow does DCTH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $22.52M minus capital expenditures of $1.55M produced free cash flow of $20.97M.
How much debt does Delcath Systems have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $101.00K and cash and equivalents of $43.45M.
DCTH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors